Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions

From Iskomunidad
mNo edit summary
mNo edit summary
Line 1: Line 1:
[[Image:Dec10_Colloquium-F1.png|500px|right]]
[[Image:Dec10_Colloquium-F1.png|500px|right]]
An [[“Ethical%2C_Legal%2C_Social_Issues”_%28ELSI%29_Program|ELSI]] Colloquium on ''' "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"'''  
An [[“Ethical%2C_Legal%2C_Social_Issues”_%28ELSI%29_Program|ELSI]] Colloquium on ''' "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"'''  
<br />
<br /><br />
10 December 2012 (Monday), 2pm<br />
'''10 December''' 2012 (Monday), '''2pm'''<br />
Buenafe Hall<br />
Buenafe Hall<br />
College of Medicine<br />
College of Medicine<br />

Revision as of 00:02, 27 October 2012

An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"

10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila

Webpage shortcut: goo.gl/xszDH

Online Registration. Please register asap, as seats are limited. Confirmation will be needed.

Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA

Organizers

  • PGC ELSI Program
  • UP Manila Research Ethics Review Board



See Also

“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center